NASC (Nascent Pharma Holdings) FCF Yield %: 23.93 (As of Jun. 25, 2026)


NASC Nascent Pharma Holdings Inc NASC
12 GF Score
Price $0.01
View Full Analysis

What is Nascent Pharma Holdings FCF Yield %?

Nascent Pharma Holdings NASC 12 FCF Yield % is 23.93 as of Jun. 25, 2026. GuruFocus rates NASC with a GF Score™ of 12/100.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nascent Pharma Holdings's Trailing 12-Month Free Cash Flow is $0.25 Mil, and Market Cap is $1.03 Mil. Therefore, Nascent Pharma Holdings's FCF Yield % for today is 23.93%.

The historical rank and industry rank for Nascent Pharma Holdings's FCF Yield % or its related term are showing as below:

NASC' s FCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 23.93
Current: 23.93


During the past 13 years, the highest FCF Yield % of Nascent Pharma Holdings was 23.93%. The lowest was 0.00%. And the median was 0.00%.

NASC's FCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.67 vs NASC: 23.93

Nascent Pharma Holdings's FCF Margin % for the quarter that ended in Sep. 2024 was 60.00%.


Nascent Pharma Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nascent Pharma Holdings FCF Yield % Related Terms


Nascent Pharma Holdings FCF Yield % Historical Data

* Premium members only.

The historical data trend for Nascent Pharma Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nascent Pharma Holdings FCF Yield % Chart

Nascent Pharma Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.15 -55.36 -38.49 -69.22 -152.13

Nascent Pharma Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.24 69.67 58.71 -55.35 4.09

NASC vs ALID, CPMD, PLSH: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nascent Pharma Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nascent Pharma Holdings FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nascent Pharma Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nascent Pharma Holdings's FCF Yield % falls into.


NASC
12GF Score
Nascent Pharma Holdings Inc NASC
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nascent Pharma Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nascent Pharma Holdings's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.319 / 0.8670005
=-152.13%

Nascent Pharma Holdings's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.009 * 4 / 0.87959185
=4.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 23.93 mean?
Nascent Pharma Holdings (NASC) has a FCF Yield % of 23.93 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nascent Pharma Holdings and its competitors.
Is Nascent Pharma Holdings' FCF Yield % too high?
Nascent Pharma Holdings' current FCF Yield % is 23.93. The Drug Manufacturers industry median FCF Yield % is 0.67. Nascent Pharma Holdings' value of 23.93 is 3471.6% above this industry median. Overall, Nascent Pharma Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Nascent Pharma Holdings' FCF Yield % compare to ALID and CPMD?
Nascent Pharma Holdings' FCF Yield % of 23.93 can be compared against companies in the Drug Manufacturers industry. The industry median FCF Yield % is 0.67. Nascent Pharma Holdings' value of 23.93 is 3471.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nascent Pharma Holdings's current FCF Yield % of 23.93 is 3471.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nascent Pharma Holdings and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nascent Pharma Holdings's current FCF Yield % is 23.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nascent Pharma Holdings stock overvalued right now?
Nascent Pharma Holdings (NASC) has a current FCF Yield % of 23.93. The current FCF Yield % is 23.93 and 3471.6% above the Drug Manufacturers industry median of 0.67. Nascent Pharma Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Nascent Pharma Holdings (NASC), the current FCF Yield % is 23.93 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nascent Pharma Holdings Business Description

Address 44 East End Avenue, Hicksville, NY, USA, 11801
Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.
12GF Score

Get the complete analysis for NASC

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price